Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Preserving clinical judgment in the age of clinical AI tools

Gerald Kuo
Conditions
December 15, 2025
Share
Tweet
Share

When I first began working with clinical AI tools, I felt the kind of excitement many young clinicians and researchers feel today. For the first time, it seemed possible to reduce cognitive overload, surface hidden patterns, and give clinicians more time to focus on what mattered most: patients. AI felt less like a threat and more like a long-awaited collaborator.

As a young clinician-scholar, I did what many of us do. I read widely, tested tools, and began writing about the implications of AI-assisted decision-making. I was not arguing against AI. I was arguing for something more specific and, I believed, more urgent: how we preserve clinical judgment in an era where machines are increasingly confident, fast, and persuasive.

The reality of academic resistance

Then reality intervened.

As my work entered formal academic review, I encountered resistance that surprised me. Not hostility, but skepticism. I was repeatedly asked to “prove” that erosion of diagnostic reasoning was already occurring, to justify why this concern deserved attention now rather than later. Some reviewers questioned whether such risks were even plausible. Others suggested that if AI improved outcomes, concerns about judgment were secondary.

What unsettled me was not rejection itself. Rejection is part of academic life. What unsettled me was the realization that the problem I was describing did not yet have a recognized name, framework, or home. Without long-term data or institutional authority, raising early warnings felt less like scholarship and more like speculation (at least in the eyes of the system).

For a time, this was deeply discouraging. It felt as though enthusiasm for AI had left little room for careful reflection, especially when that reflection came from someone early in their career. I began to wonder whether I had misunderstood my role entirely. Was I too early? Too cautious? Or simply in the wrong place?

The risk of unexamined collaboration

Eventually, I realized the issue was not whether AI should be used. That question has already been answered. The real question is how humans and AI learn to work together without diminishing what makes clinical expertise meaningful in the first place.

Clinical judgment is not a static skill. It is shaped through uncertainty, error, reflection, and responsibility. AI systems, by contrast, offer clarity without accountability. When their outputs are treated as authoritative rather than advisory, the risk is not that clinicians become obsolete, but that they become disengaged from the very reasoning processes that once defined their expertise.

This does not make AI dangerous. It makes unexamined collaboration dangerous.

Reframing the role of the clinician-scholar

What restored my sense of purpose was reframing my role, not as an opponent of AI, nor as its cheerleader, but as a translator between systems. Young clinicians and scholars occupy a unique position. We are fluent enough in technology to see its promise, yet close enough to clinical training to recognize what may be quietly lost along the way.

Hope, I have learned, does not come from blind optimism. It comes from mature collaboration. AI can support clinicians without replacing judgment, but only if we deliberately design training, workflows, and professional norms that keep humans cognitively engaged rather than deferential.

ADVERTISEMENT

For others navigating similar frustrations, especially early in their careers, I offer this reassurance: Encountering resistance does not mean your concern is invalid. It may simply mean that you are standing at the edge of a conversation that has not yet fully begun.

AI will continue to advance. The harder work (ensuring that human judgment advances alongside it) belongs to all of us. And that work is still worth doing.

Gerald Kuo, a doctoral student in the Graduate Institute of Business Administration at Fu Jen Catholic University in Taiwan, specializes in health care management, long-term care systems, AI governance in clinical and social care settings, and elder care policy. He is affiliated with the Home Health Care Charity Association and maintains a professional presence on Facebook, where he shares updates on research and community work. Kuo helps operate a day-care center for older adults, working closely with families, nurses, and community physicians. His research and practical efforts focus on reducing administrative strain on clinicians, strengthening continuity and quality of elder care, and developing sustainable service models through data, technology, and cross-disciplinary collaboration. He is particularly interested in how emerging AI tools can support aging clinical workforces, enhance care delivery, and build greater trust between health systems and the public.

Prev

What is a loving organization?

December 15, 2025 Kevin 0
…
Next

The emotional toll of trauma care

December 15, 2025 Kevin 0
…

Tagged as: Geriatrics

Post navigation

< Previous Post
What is a loving organization?
Next Post >
The emotional toll of trauma care

ADVERTISEMENT

More by Gerald Kuo

  • Why senior-friendly health materials are essential for access

    Gerald Kuo
  • How regulations restrict long-term care workers in Taiwan

    Gerald Kuo
  • Why the cannabis ethics debate is really about human suffering

    Gerald Kuo

Related Posts

  • For medical students: 20 pearls to honor every clinical rotation

    Ton La, Jr., MD, JD
  • Understanding why people participate in clinical trials

    Pouria Rostamiasrabadi
  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Physician advocacy as a core clinical skill

    Tyler D. Harvey, MPH
  • Why clinical research is a powerful path for unmatched IMGs

    Dr. Khutaija Noor
  • Finding your medical specialty: Embracing uncertainty in clinical rotations

    Khadija Khamis Ussi

More in Conditions

  • What is a loving organization?

    Apurv Gupta, MD, MPH & Kim Downey, PT & Michael Mantell, PhD
  • Why humanity in medicine requires peace with a spine

    Kathleen Muldoon, PhD
  • The loss of community pharmacy expertise

    Muhammad Abdullah Khan
  • Why senior-friendly health materials are essential for access

    Gerald Kuo
  • Why smoking is the top cause of bladder cancer

    Martina Ambardjieva, MD, PhD
  • How regulations restrict long-term care workers in Taiwan

    Gerald Kuo
  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • The emotional toll of trauma care

      Veronica Bonales, MD | Physician
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • The emotional toll of trauma care

      Veronica Bonales, MD | Physician
    • Preserving clinical judgment in the age of clinical AI tools

      Gerald Kuo | Conditions
    • What is a loving organization?

      Apurv Gupta, MD, MPH & Kim Downey, PT & Michael Mantell, PhD | Conditions
    • Why humanity in medicine requires peace with a spine

      Kathleen Muldoon, PhD | Conditions
    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • The emotional toll of trauma care

      Veronica Bonales, MD | Physician
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • The emotional toll of trauma care

      Veronica Bonales, MD | Physician
    • Preserving clinical judgment in the age of clinical AI tools

      Gerald Kuo | Conditions
    • What is a loving organization?

      Apurv Gupta, MD, MPH & Kim Downey, PT & Michael Mantell, PhD | Conditions
    • Why humanity in medicine requires peace with a spine

      Kathleen Muldoon, PhD | Conditions
    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...